Psychopharmacology (Berl)
November 2024
Rationale: The compound 5-((4-methoxyphenyl)thio)benzo[c][1,2,5]thiadiazole (MTDZ) has recently been shown to inhibit in vitro acetylcholinesterase activity, reduce cognitive damage, and improve neuropsychic behavior in mice, making it a promising molecule to treat depression.
Objectives: This study investigated the antidepressant-like action of MTDZ in mice and its potential mechanisms of action.
Results: Molecular docking assays were performed and suggested a potential inhibition of monoamine oxidase A (MAO-A) by MTDZ.
Nanomaterials (Basel)
March 2022